Literature DB >> 24526468

Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.

Pauli Puolakkainen1, Aino Koski, Sanna Vainionpää, Zhanlong Shen, Heikki Repo, Esko Kemppainen, Harri Mustonen, Hanna Seppänen.   

Abstract

Patients with chronic pancreatitis with local inflammation have high risk for pancreatic cancer. The aim of this study was to examine the role of the inflammatory cells in the invasion of pancreatic cancer cells, focusing on the involvement of a disintegrin and metalloproteinase 8 (ADAM8) and matrix metalloproteinase 9 (MMP9) proteins. ADAM8 expression is associated with worse survival of pancreatic cancer patients. Monocytes from healthy donors were differentiated into macrophages. Pancreatic adenocarcinoma cells were cultured either alone or with differentiated macrophages. The cancer cell migration rate in Matrigel was measured by imaging fluorescently stained cells for 24 h. After invasion, cells were sorted into CD14 positive/negative macrophages and cancer cells with magnetic separation. The expression of ADAM8 and MMP9 was measured by the real-time PCR. Protein-level expression of ADAM8 and MMP9 was analyzed by Western blotting. In two series, siRNA technique was used to reduce either ADAM8 or MMP9 expression in the cancer cells. The coculture with macrophages increased cancer cell migration rate in Matrigel, and increased ADAM8 and MMP9 mRNA expression and protein level in the cancer cells. Reduction of ADAM8 expression with siRNA in the cancer cells decreased macrophage-induced migration rate of the cancer cells from 11.7±0.3 μm/h to 9.0±0.2 μm/h (p<0.01), and reduction of MMP9 expression decreased the migration rate to 10.1±0.2 μm/h (p<0.01). Anti-inflammatory macrophages increase pancreatic cancer cell migration rate in basement membrane matrix by inducing ADAM8 and MMP9 expression in cancer cells, thereby possibly enhancing the invasiveness of cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24526468     DOI: 10.1007/s12032-014-0884-9

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  40 in total

Review 1.  ADAMs: key components in EGFR signalling and development.

Authors:  Carl P Blobel
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 2.  The ADAMs: signalling scissors in the tumour microenvironment.

Authors:  Gillian Murphy
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

3.  Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma.

Authors:  T Koshiba; R Hosotani; M Wada; Y Miyamoto; K Fujimoto; J U Lee; R Doi; S Arii; M Imamura
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

4.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

5.  High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Yun Zhang; Yong-Fei Tan; Chao Jiang; Kai Zhang; Tian-Zhou Zha; Miao Zhang
Journal:  Pathol Oncol Res       Date:  2012-09-12       Impact factor: 3.201

6.  Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.

Authors:  Donglei Zhang; Menashe Bar-Eli; Sylvain Meloche; Pnina Brodt
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

7.  Macrophage coculture enhanced invasion of gastric cancer cells via TGF-β and BMP pathways.

Authors:  Zhanlong Shen; Tuuli Kauttu; Jian Cao; Hanna Seppänen; Sanna Vainionpää; Yingjiang Ye; Shan Wang; Harri Mustonen; Pauli Puolakkainen
Journal:  Scand J Gastroenterol       Date:  2013-04       Impact factor: 2.423

8.  Matricellular proteins: a sticky affair with cancers.

Authors:  Han Chung Chong; Chek Kun Tan; Royston-Luke Huang; Nguan Soon Tan
Journal:  J Oncol       Date:  2012-02-09       Impact factor: 4.375

9.  Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions.

Authors:  Jae Young Choi; Yeon Soo Jang; Sun Young Min; Jeong Yoon Song
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

10.  ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.

Authors:  R Grützmann; J Lüttges; B Sipos; O Ammerpohl; F Dobrowolski; I Alldinger; S Kersting; D Ockert; R Koch; H Kalthoff; H K Schackert; H D Saeger; G Klöppel; C Pilarsky
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more
  9 in total

Review 1.  Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.

Authors:  Ibrahim H Sahin; Christine A Iacobuzio-Donahue; Eileen M O'Reilly
Journal:  Expert Opin Ther Targets       Date:  2015-10-06       Impact factor: 6.902

2.  Increasing the Inflammatory Competence of Macrophages with IL-6 or with Combination of IL-4 and LPS Restrains the Invasiveness of Pancreatic Cancer Cells.

Authors:  Aino N E Salmiheimo; Harri K Mustonen; Sanna A A Vainionpää; Zhanlong Shen; Esko A J Kemppainen; Hanna E Seppänen; Pauli A Puolakkainen
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

3.  A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.

Authors:  Wenlong Wang; Weiyang Lou; Bisha Ding; Beng Yang; Hongda Lu; Qingzhi Kong; Weimin Fan
Journal:  Aging (Albany NY)       Date:  2019-05-06       Impact factor: 5.682

4.  Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.

Authors:  Jinlin Wen; Panpan Yin; Linwei Li; Guihua Kang; Guozhu Ning; Yu Cao; Feng Gao; Ying Su; Yanlin Wu; Xinyan Zhang
Journal:  Biomed Res Int       Date:  2020-04-15       Impact factor: 3.411

Review 5.  Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming.

Authors:  Sen Yang; Qiaofei Liu; Quan Liao
Journal:  Front Cell Dev Biol       Date:  2021-01-11

6.  ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9.

Authors:  Lena Cook; Marie Sengelmann; Birte Winkler; Constanze Nagl; Sarah Koch; Uwe Schlomann; Emily P Slater; Miles A Miller; Elke Pogge von Strandmann; Bastian Dörsam; Christian Preußer; Jörg W Bartsch
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

7.  The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma.

Authors:  Xiaojin Liu; Yimin Huang; Yiwei Qi; Shiqiang Wu; Feng Hu; Junwen Wang; Kai Shu; Huaqiu Zhang; Jörg W Bartsch; Christopher Nimsky; Fangyong Dong; Ting Lei
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

8.  Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems.

Authors:  Mei-Ju Su; Hibah Aldawsari; Mansoor Amiji
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

9.  Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.

Authors:  Liumeng Jian; Guangda Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-19       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.